A Europe Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine

Europe Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)

The anaphylaxis treatment market in Europe is expected to grow from US$ 534.0 million in 2021 to US$ 987.2 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028.

Anaphylaxis is a severe, life?threatening allergic reaction caused by vulnerability to allergens (foods, insect stings, or medicines) identified as a non-self by a human body. Typical indications of this condition include swallowing and breathing difficulties, skin redness and itching, accelerated heart rate, wheezing, rapid breathing rate, and lowering blood pressure. The incidence of anaphylaxis is increasing around the world. According to the National Institute for Health and Care Excellence (NICE), anaphylaxis causes more than 20 deaths every year in the UK. As per the European Academy of Allergy and Clinical Immunology data, ~150 million Europeans suffer from chronic allergic diseases every year. Therefore, the rising incidence of allergies is leading to surge in anaphylaxis cases. Due to the growing prevalence of allergies, the economic burden on healthcare systems in many countries is increasing. Thus, the burgeoning incidence of anaphylaxis is driving the growth of the market.

The market for anaphylaxis treatment market is segmented into medication type, route of administration, allergy type, and distribution channel. Based on medication type, the anaphylaxis treatment market is segmented epinephrine, antihistamines, steroids, beta-agonist, and others. In 2020, epinephrine segment accounted for the highest share of the market. The growth of the epinephrine is attributed due to easy access to the epinephrine, rising incidences of allergic reactions and growing government policies to access epinephrine to school-going children. Additionally, the rise in the number of a product launch for generic version epinephrine is key factor responsible for the growth of the market. For instance, in July 2019, Sandoz, a Novartis AG division, has launched its generic pre-filled Symjepi epinephrine shots across the country.

The rapid growth of COVID-19 cases in Europe has had a major impact on the European economy. Spain, Italy, Germany, France, and the United Kingdom are among the European countries most affected. In collaboration with the European Academy of Allergy and Clinical Immunology (EAACI), it published “Allergy and Its Impact on Asthma (ARIA).” Experts in their respective fields recently published a compendium with answers to 150 commonly asked questions about COVID-19 and allergic diseases. Furthermore, readers can put further questions regarding this “living” compendium electronically to the authors, and their answers will be available through a new category in the journal’s webpage. Besides, EAACI, in collaboration with ARIA, has provided recommendations on operational plans and practical procedures for ensuring optimal standards in the daily clinical care of patients with allergic diseases whilst ensuring the safety of patients and healthcare workers. Therefore, growing awareness of allergy linked to COVID-19 in Europe during is likely to demand for anaphyalaxis treatment and supply in COVID Pandemic, hence it can boost the growth of the anaphylaxis treatment market.

The overall Europe anaphylaxis treatment market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining overview and forecast for the Europe anaphylaxis treatment market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who typically take part in such a process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the Europe Anaphylaxis treatment market. Amneal Pharmaceuticals Inc., Mylan N.V., BIOPROJET, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck and Co., Inc., Teva Pharmaceutical Industries Ltd., and ALK-ABELLó are among a few players operating in the Europe anaphylaxis treatment market.

Reason To Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe anaphylaxis treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe anaphylaxis treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the anaphylaxis treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution 


1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Anaphylaxis Treatment Market – By Medication Type
1.3.2 Anaphylaxis Treatment Market – By Route of Administration
1.3.3 Anaphylaxis Treatment Market – By Allergy Type
1.3.4 Anaphylaxis Treatment Market – By Distribution Channel
1.3.5 Europe Anaphylaxis Treatment Market – By Country
2. Europe Anaphylaxis Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Anaphylaxis Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anaphylaxis Treatment Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Anaphylaxis Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Anaphylaxis Treatment Market – Europe Analysis
6.1 Europe Anaphylaxis Treatment Market Revenue Forecasts and Analysis
7. Europe Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8. Anaphylaxis Treatment Market Analysis – By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Anaphylaxis Treatment Market Analysis and Forecasts to 2028– By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
11. Anaphylaxis Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 Europe: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.2.1 Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 Germany: Anaphylaxis Treatment Market, by Medication Type 2019–2028 (USD Million)
11.1.2.1.3 Germany: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.1.4 Germany: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.1.5 Germany: anaphylaxis treatment Market, by Allergy Type 2019–2028 (USD Million)
11.1.2.1.6 Germany: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.1.2.2 UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 UK: Anaphylaxis Treatment Market, Medication Type, 2019–2028 (USD Million)
11.1.2.2.3 UK: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.2.4 UK: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.2.5 UK: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)
11.1.2.2.6 UK: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.1.2.3 France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 France: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.3.3 France: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.3.4 France: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)
11.1.2.3.5 France: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)
11.1.2.3.6 France: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)
11.1.2.4 Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 Italy: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.4.3 Italy: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.4.4 Italy: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.4.5 Italy: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.4.6 Italy: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.5 Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.1 Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.2 Spain: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.5.3 Spain: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.5.4 Spain: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.5.5 Spain: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.5.6 Spain: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.6 Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.1 Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.2 Rest of Europe: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.6.3 Rest of Europe: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.6.4 Rest of Europe: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.6.5 Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.6.6 Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Europe Anaphylaxis Treatment Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.2 ALK-Abelló A/S
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Amneal Pharmaceuticals, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BIOPROJET
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 MYLAN N.V.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
List of Tables
Table 1. Germany: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Germany: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 10. UK: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)
Table 11. France: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 12. France: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 13. France: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. France: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 15. France Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 17. Italy: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 18. Italy: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 20. Italy: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 22. Spain: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 23. Spain: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 24. Spain: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 25. Spain: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Europe: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 31. Organic Developments Done by Companies
Table 32. Inorganic Developments Done by Companies
Table 33. Glossary of Terms, Anaphylaxis Treatment Market
List of Figures
Figure 1. Anaphylaxis Treatment Market Segmentation
Figure 2. Europe Anaphylaxis Treatment Market Overview
Figure 3. Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Anaphylaxis Treatment Market - Europe PEST Analysis
Figure 6. Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints
Figure 7. Europe Anaphylaxis Treatment Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
Figure 9. Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)
Figure 15. Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)
Figure 19. Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
Figure 24. Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 27. Europe: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 28. Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in European Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook